CONCLUSION

Launch Like a Veteran

Launch Like a Veteran

Emerging biopharmas are reshaping the future of medicine. But even the most innovative therapies require exceptional commercialization to reach the patients who need them.

With a unified, modern, AI-enabled launch readiness hub, emerging biopharma can:

Operate with the discipline of large pharma
Move with the agility of a startup
Equip reps with confidence and scientific fluency
Have real-time insights into field performance
Create a launch trajectory that drives long-term success

You do not need a massive team. You do not need a sprawling tech stack. You do not need years of commercial infrastructure.

What you do need is one unified platform that prepares your people, aligns your messaging, accelerates your readiness, and powers your launch.

That is how emerging companies become enduring ones.

Notes

¹PhRMA, "Research and development continues long after a medicine is initially approved" https://phrma.org/blog/research-and-development-continues-long-after-a-medicine-is-initially-approved

²IQVIA, "Launch Excellence VIII: The challenge of change: building Excellent launches in the post-pandemic environment" https://www.iqvia.com/-/media/iqvia/pdfs/library/white-papers/iqvia-launch-excellence-viii.pdf

³McKinsey & Company, “The Early Years of a Pharmaceutical Product Launch,” https://www.mckinsey.com/.

⁴ACTO, “Launching with Confidence: Empowering a Specialized Field Force for a Pediatric Formula” https://turtl.acto.com/story/case-study-launching-with-confidence-empowering-a-specialized-field-force-for-a-pediatric-formula/page/1

⁵ACTO, “Proving Coaching ROI: A Pharma Field-Force Transformation” https://turtl.acto.com/story/case-study-proving-coaching-roi-a-pharma-field-force-transformation/page/1

Did you find this content useful?

Yes, definitely useful
Somewhat useful
Not useful at all

About ACTO

Trusted by 14 of the top 50 pharmaceutical companies, high-growth biotechs, and leading medtech organizations, ACTO is redefining how therapies reach patients after regulatory approval. We unite human intelligence with empathetic AI through our AI-powered Field Excellence Platform and AI SuperAgents to accelerate product launches, strengthen field execution, and deepen customer engagement. By elevating training and coaching while agentifying up to 30% of the work embedded in customer-facing roles, ACTO frees teams to focus on what matters most: human connection, judgment, and strategic execution. Built to meet the industry’s highest regulatory standards, ACTO is FDA 21 CFR Part 11 validated and SOC 2 Type II certified.